Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biomarker Development Meeting May Help Expand Accelerated Approval

21 Jul 2014

• By Derrick Gingery

Related Content

PDUFA V: Final Recommendations Fund Proposals In Two Of Three Tiers

02 May 2011

For Combination Product Development, Industry Says Talk Is Cheap

28 Jan 2013

Paging Dr. McClellan: FDA Calls On Brookings For PDUFA Research

12 Mar 2013

FDA Flexible With Accelerated Approval Evidence, Analysis Finds

02 Sep 2013

Biomarkers In Orphan Studies Still Need Past Experience, FDA Says

27 May 2013

Additional Topics

United States Drug Approval Standards BioPharmaceutical Medical Device

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.